⌘K
Loading ticker…
Q32 Bio Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Q32 Bio Inc. Common Stock (QTTB) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 99. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 13.3%, relative volume 0.81×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 95, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
QTTB is in a stage 2 uptrend, week 5. Currently in a 15-day base; basing ADR 11.9% (broad 12.5%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 51.6% / 166.1%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
QTTB is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $1M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $1M |
| VXFVanguard Extended Market ETF | 0.00% | $768K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | QTTB Jan avg: 2.47% median: 2.47% win: 50% σ: 20.36% n: 2 2024-03-27 → 2026-05-29 | QTTB Feb avg: -3.78% median: -3.78% win: 50% σ: 30.13% n: 2 2024-03-27 → 2026-05-29 | QTTB Mar avg: 5.27% median: 2.34% win: 67% σ: 34.15% n: 3 2024-03-27 → 2026-05-29 | QTTB Apr avg: 15.00% median: -3.03% win: 33% σ: 39.96% n: 3 2024-03-27 → 2026-05-29 | QTTB May avg: 32.84% median: 8.13% win: 67% σ: 56.35% n: 3 2024-03-27 → 2026-05-29 | QTTB Jun avg: -21.74% median: -21.74% win: 0% σ: 11.13% n: 2 2024-03-27 → 2026-05-29 (current) | QTTB Jul avg: 80.57% median: 80.57% win: 100% σ: 44.66% n: 2 2024-03-27 → 2026-05-29 | QTTB Aug avg: -4.40% median: -4.40% win: 50% σ: 26.27% n: 2 2024-03-27 → 2026-05-29 | QTTB Sep avg: 9.21% median: 9.21% win: 100% σ: 9.31% n: 2 2024-03-27 → 2026-05-29 | QTTB Oct avg: 23.88% median: 23.88% win: 100% σ: 25.50% n: 2 2024-03-27 → 2026-05-29 | QTTB Nov avg: -32.54% median: -32.54% win: 0% σ: 14.82% n: 2 2024-03-27 → 2026-05-29 | QTTB Dec avg: -17.81% median: -17.81% win: 50% σ: 98.16% n: 2 2024-03-27 → 2026-05-29 |